Real-time enrollment status for this hemophilia clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 11:14 AM UTC
| NCT Number | NCT05568719 |
| Recruiting Status | Recruiting |
| Condition | Hemophilia |
| Phase | PHASE3 |
| Target Enrollment | 173 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | May 27, 2026 (May 27, 2026) |
As of July 19, 2026: Clinical trial NCT05568719 is currently recruiting participants. This phase3 study for hemophilia is actively seeking new participants at 14 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05568719 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05568719 was last updated May 27, 2026 (May 27, 2026). HelloStudys verifies this status automatically.